Completed PHASE2 INTERVENTIONAL 2-arm NCT00317291

Acupuncture/Moxibustion for Peripheral Neuropathy in HIV

Acu/Moxa for Peripheral Neuropathy in Persons With HIV

Sponsor: National Center for Complementary and Integrative Health (NCCIH)

Conditions HIV Infections Peripheral Neuropathies

Interventions Acupuncture/Moxibustion Sham acupuncture/Placebo moxibustion

Updated 6 times since 2017 Last updated: Sep 10, 2019 Started: Nov 30, 2005 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00317291, this PHASE2 trial focuses on HIV Infections and Peripheral Neuropathies and remains completed. Sponsored by National Center for Complementary and Integrative Health (NCCIH), it has been updated 6 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Oct 2019 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Oct 2019 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Complementary and Integrative Health (NCCIH)

Data source: National Center for Complementary and Integrative Health (NCCIH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States